ストックスクリーナーアプリを入手
329.89
3.07%
-10.44
アフターアワーズ：
329.49
-0.40
-0.12%
Amgen Inc (AMGN) 最新ニュース
A Closer Look at Amgen (AMGN) Valuation After Its 12-Month 28% Share Price Gain - simplywall.st
Erste Group upgrades Amgen stock rating to Buy from Hold on obesity drug - Investing.com
Amgen (NASDAQ:AMGN) Rating Increased to Buy at Erste Group Bank - MarketBeat
Amgen Named Official Biotech Partner by Los Angeles Sports & Entertainment Commission (LASEC) Ahead of FIFA World Cup 2026 - Amgen
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock - Yahoo Finance
Tema Etfs LLC Has $3.62 Million Stock Holdings in Amgen Inc. $AMGN - MarketBeat
What makes Amgen Inc. (AMG0) stock appealing to growth investorsMarket Performance Recap & Smart Money Movement Alerts - Newser
Is Amgen Inc. (AMG0) stock overpriced at current multiplesEarnings Risk Report & Long-Term Investment Growth Plans - Newser
First Trust Advisors LP Sells 21,347 Shares of Amgen Inc. $AMGN - MarketBeat
Beutel Goodman & Co Ltd. Raises Position in Amgen Inc. $AMGN - MarketBeat
Baird Financial Group Inc. Cuts Position in Amgen Inc. $AMGN - MarketBeat
Arrowstreet Capital Limited Partnership Makes New Investment in Amgen Inc. $AMGN - MarketBeat
Why Is Amgen (AMGN) Up 8% Since Last Earnings Report? - Yahoo Finance
Pharmaceutical Marketing Industry Trends and Emerging Opportunities 2025-2032 Featuring Syneos Health, McCann Health, Amgen, AXPIRA, Pfizer and MoreResearchAndMarkets.com - Markets Financial Content
Amgen (NASDAQ:AMGN) Shareholders Have Earned a 12% CAGR Over the Last Five Years - 富途牛牛
Amgen: Stagnation And The IRS Are Coming (NASDAQ:AMGN) - Seeking Alpha
Does Amgen Stock Lead the Pack? - Trefis
3 Top ETFs I Plan to Pile Into in December to Boost My Passive Income in 2026 - The Motley Fool
EverSource Wealth Advisors LLC Cuts Position in Amgen Inc. $AMGN - MarketBeat
Guggenheim Capital LLC Boosts Stake in Amgen Inc. $AMGN - MarketBeat
Will Strong Q3 Beat And Pipeline Updates Change Amgen's (AMGN) Future Earnings Narrative? - simplywall.st
BMO Capital Maintains Amgen (AMGN) Outperform Recommendation - Nasdaq
Amgen (NASDAQ:AMGN) Reaches New 12-Month HighStill a Buy? - MarketBeat
Analyst Says Viridian's New Thyroid Eye Drug Could Outperform Amgen's Tepezza - Benzinga
Key facts: Amgen reports strong growth; BMO raises price target to $372 - TradingView
Amgen stock hits 52-week high at $345.95 By Investing.com - Investing.com Nigeria
Amgen stock hits 52-week high at $345.95 - Investing.com
Amgen (AMGN) Stock Hits New 52‑Week High as Obesity Drug Bets and Analyst Upgrades Fuel 2025 Rally - ts2.tech
Biocon and Amgen Reach Deal to Commercialise Biosimilars in Europe - Chemical Industry Digest
BMO Capital Raises Price Target for Amgen (AMGN) to $372, Mainta - GuruFocus
BMO Capital Adjusts Price Target on Amgen to $372 From $335, Maintains Outperform Rating - marketscreener.com
Invesco Ltd. Buys 339,755 Shares of Amgen Inc. $AMGN - MarketBeat
UPC Court Of Appeal Overturns Revocation Of Amgen's PCSK9 Antibody Patent And Clarifies The UPC's Inventive Step Approach (Amgen v Sanofi And Regeneron) - MarketScreener
Goldman Sachs Maintains Price Target on Amgen (AMGN) Before Key Trial Readouts - Insider Monkey
Extensive-Stage Small Cell Lung Cancer Market Growth to Accelerate in Forecast Period (2024-2034), DelveInsight Analyzes | EpicentRx, Ipsen, Bristol-Myers Squibb, Xcovery Holding Company, Amgen - Barchart.com
M&T Bank Corp Sells 61,385 Shares of Amgen Inc. $AMGN - MarketBeat
Bio Meets Tech: How Amgen is Designing the Medicines of Tomorrow - Amgen
OMERS ADMINISTRATION Corp Cuts Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Biocon Biologics settles with Amgen to launch Denosumab Biosimilars in Europe, rest of the world - Zee Business
Biocon Biologics settles with Amgen Inc to commercialise biosimilars in Europe - Daily Excelsior
How the Story Behind Amgen Is Shifting After Pipeline and Guidance Updates - Yahoo Finance
Amgen Inc. $AMGN Shares Sold by Fisher Asset Management LLC - MarketBeat
Edgestream Partners L.P. Buys 12,318 Shares of Amgen Inc. $AMGN - MarketBeat
Beacon Pointe Advisors LLC Sells 4,768 Shares of Amgen Inc. $AMGN - MarketBeat
Is Amgen Inc. (AMG) stock supported by strong fundamentals2025 Major Catalysts & Reliable Entry Point Trade Alerts - Newser
Amgen (AMGN): Company Profile, Stock Price, News, Rankings - Fortune
How strong is Amgen Inc. (AMG0) stock earnings growthJuly 2025 Short Interest & Risk Controlled Swing Alerts - Newser
Biocon Biologics reaches settlement with Amgen for Denosumab biosimilars commercialisation - Express Pharma
Biocon Biologics announces settlement agreement with Amgen Inc. - Business Standard
Amgen Stock (AMGN) Today: Q3 2025 Earnings Beat, MariTide Obesity Drug Outlook and 2030 Price Forecast - ts2.tech
Is the Market Bullish or Bearish on Amgen Inc? - Benzinga
Panagora Asset Management Inc. Has $136.94 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN is Round Hill Asset Management's 2nd Largest Position - MarketBeat
Amgen Inc. $AMGN Shares Sold by Mackenzie Financial Corp - MarketBeat
Northwestern Mutual Wealth Management Co. Grows Position in Amgen Inc. $AMGN - MarketBeat
Distillate Capital Partners LLC Invests $25.45 Million in Amgen Inc. $AMGN - MarketBeat
Icon Advisers Inc. Co. Sells 3,500 Shares of Amgen Inc. $AMGN - MarketBeat
Boston Family Office LLC Boosts Stake in Amgen Inc. $AMGN - MarketBeat
FDA Action Alert: BMS, GSK, Amgen and More - BioSpace
Is Amgen Inc. stock a top momentum playWeekly Trend Report & Growth Focused Stock Reports - moha.gov.vn
Railway Pension Investments Ltd Has $24.60 Million Holdings in Amgen Inc. $AMGN - MarketBeat
Legacy Capital Wealth Partners LLC Lowers Position in Amgen Inc. $AMGN - MarketBeat
Schroder Investment Management Group Decreases Stock Position in Amgen Inc. $AMGN - MarketBeat
Hamel Associates Inc. Increases Stock Holdings in Amgen Inc. $AMGN - MarketBeat
Is Amgen’s Recent Rally Justified After Strong Clinical Trial Results? - Yahoo Finance
Is Now the Right Time to Revisit Amgen After Its Recent 18% Price Surge? - simplywall.st
West Family Investments Inc. Has $762,000 Holdings in Amgen Inc. $AMGN - MarketBeat
Stablepoint Partners LLC Buys 990 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen Inc. $AMGN Shares Sold by New York State Common Retirement Fund - MarketBeat
Groupama Asset Managment Sells 2,736 Shares of Amgen Inc. $AMGN - MarketBeat
Amgen (NASDAQ:AMGN) Rating Increased to Strong-Buy at Wall Street Zen - MarketBeat
Berry Wealth Group LP Buys New Holdings in Amgen Inc. $AMGN - MarketBeat
0.98%
1.28%
大文字化:
|
ボリューム (24 時間):